Healthcare
Live Price
Offline$12.90
+2.30% today
1Y Change
+40.56%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 245 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Zevra Therapeutics, Inc. (ZVRA) is a Healthcare stock with a market cap of $590.00M and listed on NASDAQ. The stock last traded around $12.90 and up 40.6% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of +350.9%, EPS growth of +161.4%, a dividend yield of 0.0%. What stands out right now is revenue +350.9%, EPS +161.4%, free cash flow +96.5% with operating margin -59.1% and ROIC -24.6%. Valuation is more restrained than many high-expectation growth names at P/E 6.7 and price/sales 5.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines ZVRA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
ZVRA
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
ZVRA Max Drawdown
-43.47%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for ZVRA and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.